scispace - formally typeset
B

Barbara A. Cornblatt

Researcher at The Feinstein Institute for Medical Research

Publications -  289
Citations -  16349

Barbara A. Cornblatt is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Psychosis & Prodrome. The author has an hindex of 63, co-authored 253 publications receiving 14246 citations. Previous affiliations of Barbara A. Cornblatt include Hofstra University & Yale University.

Papers
More filters
Journal ArticleDOI

The Field of Schizophrenia: Strengths, Weaknesses, Opportunities, and Threats

TL;DR: This issue commemorates the seminal contributions of Eugene Bleuler and is confronted with a climate in which the lay press finds occasion to call into question the very real progress that has been made in the understanding and treatment of mental illnesses.
Journal ArticleDOI

Overview of the First Annual Workshop on the Schizophrenia Prodrome

TL;DR: This report summarizes the five major topics discussed throughout the workshop: (1) vulnerability and risk factors, (2) developmental issues, (3) neuroimaging and cognition, (4) alternative prevention strategies, and (5) clinical trials.
Journal ArticleDOI

White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.

TL;DR: In this paper, the authors track the evolution of white matter abnormalities in a large, longitudinal cohort of clinical high risk individuals comprising the North American Prodrome Longitudinal Study (NAPLS-3) and fit linear mixed effects models to infer the impact of age and illness onset on variation in the fractional anisotropy of cellular tissue and the volume fraction of extracellular free water (FW).
Journal ArticleDOI

Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.

TL;DR: Baseline negative symptoms and thought disorder appear to predict functional outcome for up to two years among adolescents and young adults at risk for psychosis and developing effective interventions to target these symptoms may be critical to promote functional recovery.